Compositions and methods for efficient AAV vector production

Details Compositions and methods for efficient AAV vector production Compositions and methods for efficient AAV vector production

2007-04-24

2007-04-24

Chen, Stacy B. (Department: 1648)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S320100, C424S233100

Reexamination Certificate

active

10169785

ABSTRACT:
The present invention provides packaging cell lines for the efficient production of an Adeno-associated virus (AAV) vector which does not require “helper” virus function for the replication and encapsidation of the AAV vector particles. Packaging cells, methods for their production and methods for producing recombinant AAV vector particles useful for human gene therapy are provided.

REFERENCES:
patent: 6004797 (1999-12-01), Colosi
patent: 98/27204 (1998-06-01), None
patent: 95/20671 (1998-08-01), None
Xiao et al. Gene Therapy Vectors Based on Adeno-Associated Virus Type 1, Journal of Virology, May 1999, 73(5):3994-4003.
Verma et al. Gene Therapy-promises, problems and prospects, Nature, 1997, 389:239-242.
Orkin et al. Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, Dec. 1995, 39 pages, available from http://www.nih.gov
ews/panelrep.html.
Rose, “Parvovirus Reproduction,”Comprehensive Virology, 3:1-61 (1974).
Graham et al., “Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,”Virology,36:59-74 (1977).
Jay et al., “Eukaryotic translational control:Adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein,”Proc. Natl. Acad. Sci. USA, 78:2927-2937 (1981).
Richardson and Westphal, “Requirement for Either Early Region 1a or Early Region 1b Adenovirus Gene Products in the Helper Effect for Adeno-Associated Virus,”Journal of Virology,51:404-410 (1984).
Laughlin et al., “Latent Infection of KB Cells with Adeno-Associated Virus Type 2,”Journal of Virology, 60:515-524 (1986).
Tratschin et al., “Negative and Positive Regulation intransof Gene Expression from Adeno-Associated Virus Vectors in Mammalian Cells by a Viral rep Gene Product,”Molecular and Cellular Biology,6:2884-2894 (1986).
Samulski et al., “A Recombinant Plasmid from Which an Infectious Adeno-Associated Virus Genome Can Be Excised In Vitro and Its Use To Study Viral Replication,”Journal of Virology,61:3096-3101 (1987).
West et al., “Gene Expression in Adeno-Associated Virus Vectors: The Effects of Chimeric mRNA Structure, Helper Virus, and Adenovirus VA, RNA,”Virology,160:38-47 (1987).
Beaton et al., “Expression from the Adeno-Associated Virus p5 and p19 Promoters Is Negatively Regulated intransby therepProtein,”Journal of Virology,63:4450-4454 (1989).
Chang et al., “Adeno-Associated Virus P5 Promoter Contains an Adenovirus E1A-Inducible Element and a Binding Site for the Major Late Transcription Factor,”Journal of Virology,63:3479-3488 (1989).
Samulski et al., “Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression,”Journal of Virology,63:3822-3828 (1989).
Sandler and Ketner,“Adenovirus Early Region 4 Is Essential for Normal Stability of Late Nuclear RNAs,”Journal of Virology,63:624-630 (1989).
Chang and Shenk, “The Adenovirus DNA-Binding Protein Stimulate the Rate of Transcription Directed by Adenovirus and Adeno-Associated Virus Promoters,”Journal of Virology,64:2103-2109 (1990).
McCarty et al., “Sequences Required for Coordinate Induction of Adeno-Associated Virus p19 and p40 Promoters by Rep Protein,”Journal of Virology,65:2936-2945 (1990).
Shi et al., “Transcriptional Repression by YY1, a Human GLI-Krüppel-Related Protein, and Relief of Repression by Adenovirus E1A Protein,”Cell, 67:377-388 (1991).
Muzyczka, “Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells,”Current Topics in Microbiology and Immunology,158:97-129 (1992).
Flotte et al., “Stablein vivoexpression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector,”Proc. Natl. Acad. Sci. USA,90:10613-10617 (1993).
Nordqvist et al., “Human Adenovirus Encodes Two Proteins Which Have Opposite Effects on Accumulation of Alternatively Spliced mRNAs,”Molecular and Cellular Biology,14:437-445 (1994).
Clark et al., “Cell Lines for the Production of Recombinant Adeno-Associated Virus,”Human Gene Therapy,6:1329-1341 (1995).
Halbert et al., “Adeno-Associated Virus Vectors Transduce Primary Cells Much Less Efficiently than Immortalized Cells,”Journal of Virology,69:1473-1479 (1995).
Hörer et al., “Mutational Analysis of Adeno-Associated Virus Rep Protein-Mediated Inhibition of Heterologous and Homologous Promoters,”Journal of Virology,69:5485-5496 (1995).
Kyöstiö et al., “Negative Regulation of the Adeno-Associated Virus (AAV) P5Promoter Involves both the P5Rep Binding Site and the Consensus ATP-Binding Motif of the AAV Rep68 Protein,”Journal of Virology,69:6787-6796 (1995).
Lewis et al., “Adenovirus EIA Proteins Interact with the Cellular YY1 Transcription Factor,”Journal of Virology,69:1628-1636 (1995).
Scaria et al., “Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes,”Gene Therapy,2:295-298 (1995).
Zaitlin et al., “Alveolar stem cell transduction by an adeno-associated viral vector,”Gene Therapy,2:623-631 (1995).
Ferrari et al., “Second-Strand Synthesis Is a Rate-Limiting Step for Efficient Transduction by Recombinant Adeno-Associated Virus Vectors,”Journal of Virology,70:3227-3234 (1996).
Kessler et al., “Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein,”Proc. Natl. Acad. Sci. USA,93:14082-14087 (1996).
Allen et al., “Identification and Elimination of Replication-Competent Adeno-Associated Virus (AAV) That Can Aris by Nonhomologous Recombination during AAV Vector Production,”Journal of Virology,71:6816-6822 (1997).
Clark et al., “Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle,”Human Gene Therapy,8:659-669 (1997).
Fisher et al., “Recombinant adeno-associated virus for muscle directed gene therapy,”Nature Medicine,3:306-312 (1997).
Herzog et al., “Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus,”Proc. Natl. Acad. Sci. USA,94:5804-5809 (1997).
Koeberl et al., “Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors,”Proc. Natl. Acad. Sci. USA,94:1426-1431 (1997).
Leppard, “E4 gene function in adenovirus, adenovirus vector and adeno-associated virus infections,”Journal of General Virology,78:2131-2138 (1997).
Li et al., “Role for Highly RegulatedrepGene Expression in Adeno-Associated Virus Vector Production,”Journal of Virology,71:5236-5243 (1997).
Synder et al., “Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors,”Nature Genetics,16:270-276 (1997).
Weger et al., “Control of Adeno-Associated Virus Type 2 Cap Gene Expression: Relative Influence of Helper Virus, Terminal Repeats, and Rep Proteins,”Journal of Virology,71:8437-8447 (1997).
Xiao et al., “Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABAAα1containing receptors and increases inferior collicular seizsure sensitivity,”Brain Research,756:76-83 (1997).
Gao et al., “High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus,”Human Gene Therapy,9:2353-2362 (1998).
Grimm et al., “Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors,”Human Gene Therapy,9:2745-2760 (1998).
Halbert et. al., “Successful Readministration of Adeno-Associated Virus Vectors to the Mouse Lung

Affiliated with

Also associated with

Rating

Compositions and methods for efficient AAV vector production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for efficient AAV vector production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for efficient AAV vector production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3803023